Professor Alan Ashworth starts as CEO
Professor Alan Ashworth FRS takes over as Chief Executive of The Institute of Cancer Research (ICR)
Talented, visionary and respected around the globe, Professor Ashworth joined the ICR in 1986 and has been Director of the Breakthrough Breast Cancer Research Centre at the ICR since 1999. He is a Professor of Molecular Biology, a Fellow of the Royal Society and a world leader in cancer research.
Professor Ashworth comments on his post: “I am honoured and thrilled to lead such a respected organisation with a proud 100-year history of achievement in cancer research.”
One of Professor Ashworth’s major contributions to cancer research has been his work on genes involved in cancer risk. He was a key part of the team that in 1995 discovered the gene BRCA2, which is linked to an increased risk of some types of cancers. Ten years later, Professor Ashworth identified a way to exploit genetic weaknesses in cancer cells including mutated BRCA2, leading to a new approach to cancer treatment.
His current research reflects his passion for the development of personalised cancer medicine, translating laboratory studies into improvements in patient care.
Professor Ashworth adds; “I am very excited by the opportunity to build on the ICR’s considerable successes in improving the lives of people with cancer. As we move into an era of targeting treatments at the specific causes of the individual patient’s cancer, the ICR together with its partner, The Royal Marsden, is uniquely positioned to ensure new research discoveries benefit patients as quickly as possible.”
Professor Ashworth starts as CEO from 17 January 2011.
